Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01693484 · ClinicalTrials.gov registry record · Phase 2
Application of Indocyanine Green Angiography for Closed Operative Calcaneus Fractures
A Phase 2 study, sponsored by Louisiana State University Health Sciences Center Shreveport.
- Terminated
- Registry status
- Phase 2
- Development phase
- 13
- Enrollment target
NCT01693484 is a Phase 2 study that was terminated before completion, run by Louisiana State University Health Sciences Center Shreveport. The registered enrollment target is 13 participants.
The verdict
NCT01693484, a Phase 2 study, was terminated before completion, sponsored by Louisiana State University Health Sciences Center Shreveport.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 13 participants
- Enrollment target
Study Summary
Researchers in the Orthopaedic surgery department at LSU Medical Center-Shreveport hope to learn if patterns of blood-flow around the incision site of patients undergoing surgery for heel-bone fractures can help predict whether complications will arise after a specific type of operation.The goals of this research study are to effectively answer as many of the following research questions as possible: 1. Can a drug normally used to evaluate adequate blood flow in plastic surgery and tissue transfer be used to identify altered patterns of blood flow at the operative site of Calcaneus fractures, when compared to the uninjured extremity? 2. Are changes in blood flow identifiable at the operative site post operatively? 3. Are there certain patterns of blood flow present preoperatively or postoperatively that can predict wound complication? 4. Can certain patterns of blood flow predict the location of slough or dehiscence after surgery? 5. Does the incision site and its proximity to specific patterns of blood flow possibly predict wound complication? The hypothesis is that the study drug will show a correlation between certain patterns of blood flow and whatever post-operative complications may arise.
Interventions
- DRUG ICG (Indocyanine Green)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2013-04 |
| Est. Completion | 2015-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01693484
The ClinicalTrials.gov registry entry for NCT01693484 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Louisiana State University Health Sciences Center Shreveport, which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ICG (Indocyanine Green) is the first listed.
NCT01693484 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01693484 about?
NCT01693484 is a clinical study titled "Application of Indocyanine Green Angiography for Closed Operative Calcaneus Fractures". Researchers in the Orthopaedic surgery department at LSU Medical Center-Shreveport hope to learn if patterns of blood-flow around the incision site of patients undergoing surgery for heel-bone fractures can help predict whether complications will arise after a specific type of operation.The goals of...
What is the current status of trial NCT01693484?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 13 participants. The study started on 2013-04. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01693484?
The interventions under investigation include: ICG (Indocyanine Green) (DRUG).
Who is sponsoring clinical trial NCT01693484?
This trial is sponsored by Louisiana State University Health Sciences Center Shreveport, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.